|Slogan||Helping Muscle and Brain Work Together|
|Key people|| Sanjai Murali |
Gary Krasilovsky, PhD
Gordon Silverman, PhD
(late) Joseph Brudny, MD
|Number of employees||1-10|
JOGO Health is a prescription digital therapeutic company that treats neuromuscular diseases such as stroke, spinal cord injury, cerebral palsy, bell's palsy and urinary and fecal incontinence.
JOGO helps healthy brain cells rewire to work with muscles that have become inactive due to stroke and other neuro-muscular conditions. In pre-clinical studies in over 1000 patients across many neuro-muscular conditions, JOGO has shown to improve outcome in treating the root causes of many neuro-muscular conditions associated with stroke, spinal cord injury, fibromyalgia, migraine, dysphagia, patellofemoral pain syndrome, cerebral palsy, bell's palsy and urinary and fecal incontinence. JOGO is composed of wearable wireless s/EMG sensors, and a patent protected Mobile App that provide treatment protocols and games that can be adapted for muscle relaxation, movement coordination, and neuro-muscular re-education, all leveraging neural plasticity.
The word "jogo" means “game” in Portuguese and the founders tribute to the pioneering work of Dr. Joe Brudny and Dr. Gordon Silverman in the field of EMG biofeedback. JOGO is the creation of entrepreneurs, product design specialists, technology enthusiasts, physical therapy professionals, physiatrists, data scientists, and game designers who have re-imagined the science of EMG Biofeedback for the era of prescription digital therapeutics.
- 2010 - An academic research conducted by Dr. Joe Brudny and Dr. Gordon Silverman of Manhattan College, NY was commissioned for commercialization
- 2019 JOGO received the patent for the innovation from United States Patent and Trademark Office (USPTO)
- 2019 Clinical testing for JOGO started
Someone in the United States has a stroke every 40 seconds. Every year, worldwide, more than 15 million people have a stroke, 795,000 people in the United States alone. 3 in 1000 children are born with cerebral-palsy. 35% of adult women and 75% of Multiple Sclerosis patients have stress urinary incontinence(SUI). Although the benefits of EMG biofeedback have been studied in academic research for more than 30 years to treat the root cause of these conditions, it was rarely tested in a rigorous clinical setting required to make it a digital therapeutic option for medical professionals to prescribe to patients. JOGO is the prescription digital therapeutics product in the EMG biofeedback space.